CDC Panel Recommends Moderna, Pfizer Vaccines Over J&J’s

An anonymous reader quotes a report from Reuters: A panel of outside advisers to the U.S. Centers for Disease Control and Prevention on Thursday voted to recommend Americans choose to receive one of the other two authorized COVID-19 vaccines over Johnson & Johnson's shot, due to rare but sometimes fatal cases of blood clotting. The CDC's Advisory Committee on Immunization voted unanimously to make the recommendation in favor of the vaccines made by Moderna and Pfizer/BioNTech over the J&J shot. The regulator still needs to sign off on the guidance. Fewer Americans have received the J&J shot than the other two vaccines by a significant margin. Out of more than 200 million fully vaccinated people in the United States, around 16 million received J&J's vaccine, according to CDC data. [...] Members of the panel also said J&J's vaccine is less effective in preventing COVID-19 than the other two authorized vaccines. In a presentation to the committee, a leading J&J vaccine scientist said the vaccine generates a strong and long-lasting immune response with just a single shot.

Read more of this story at Slashdot.